RE:RE:RE:RE:RE:RE:Smart Money Accumulating ? Bullknit - I would have never invested in Inmed if I didn't believe in the science. I aways felt that what we were being told was legit and had potential. My big issue is with Adams. He has really slow rolled this company while being less than transparent along the way. It is not acceptable to ignore investors calls and emails and delaying literally every milestone along the way.
This coming June will mark his 5 year anniversary with the company. Honestly, the biosynthesis manufacturing system isn't anywhere near where it should be. I have been told that the relationship with Almac is basically over which is why they decided to pivot to Baymedica. This - in some peoples opinion - is a "hail mary" attempt to see if there's anything viable about the system. Why else would you need Baymedica?? Remember, Adams has been adamant that he wanted to keep 100% of the rights of biosynthesis program, now all the sudden he is interested in a licensing deal? Goes against everything he has said all along.
I spoke to some people who are very intelligent in this industry and asked them "why is it that when the subject of cannabinoid biosynthesis comes up, no one ever mentions Inmed?" Their answers were all the same - "Inmed's IP isn't strong and they have yet to offer any insight as to the current viability". Remember, these are the same people who are seeing the PCT'S as they become available and are not worried that Inmed will be a viable competitor yet. That may change, but that's how they are viewed by their peers currently.
My fear is thats why Dr. Hossain left - he knew they hit a brick wall. Thats why Blacher and Bott left as well. Adams has only filled positions with his buddies from other companies mostly. Something just doesn't smell right.